Editorial: The Neurovascular Unit as a Potential Biomarker and Therapeutic Target in Cerebrovascular Disease

被引:2
|
作者
Nizari, Shereen [1 ,2 ]
Hawkes, Cheryl A. [3 ]
Hattori, Yorito [4 ]
Mishra, Anusha [5 ,6 ]
机构
[1] UCL, Ctr Adv Biomed Imaging, Div Med, London, England
[2] UCL, Ctr Cardiovasc & Metab Neurosci, Dept Neurosci Physiol & Pharmacol, London, England
[3] Univ Lancaster, Dept Biomed & Life Sci, Lancaster, England
[4] Natl Cerebral & Cardiovasc Ctr, Dept Neurol, Suita, Japan
[5] Oregon Hlth & Sci Univ, Knight Cardiovasc Inst, Portland, OR USA
[6] Oregon Hlth & Sci Univ, Jungers Ctr Neurosci Res, Dept Neurol, Portland, OR USA
来源
关键词
neurovascular unit (NVU); cerebrovascular disease; biomarker; cerebral blood flow (CBF); therapeutic target;
D O I
10.3389/fnagi.2022.908716
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
引用
收藏
页数:2
相关论文
共 50 条
  • [31] Transgelin in bladder cancer: A potential biomarker and therapeutic target
    Li, Wei-Ming
    Wu, Wen-Jeng
    EBIOMEDICINE, 2019, 48 : 16 - 17
  • [32] Circular RNA in Retina: a potential biomarker and therapeutic target
    Tian, Huiwen
    Zhao, Lu
    Li, Hongyang
    Huang, Yingxiang
    Wang, Yanling
    OPHTHALMIC RESEARCH, 2023, 66 (01) : 516 - 528
  • [33] Reticulocalbin 2 as a Potential Biomarker and Therapeutic Target for Atherosclerosis
    Li, Jing
    Taylor, Angela M.
    Manichaikul, Ani
    Angle, John F.
    Shi, Weibin
    CELLS, 2022, 11 (07)
  • [34] Bilirubin: A Potential Biomarker and Therapeutic Target for Diabetic Nephropathy
    Hull, Travis D.
    Agarwal, Anupam
    DIABETES, 2014, 63 (08) : 2613 - 2616
  • [35] Periostin: A Potential Biomarker and Therapeutic Target in Pulmonary Diseases
    Alzobaidi, Nafaa
    Rehman, Sana
    Naqvi, Maaz
    Gulati, Kavita
    Ray, Arunabha
    JOURNAL OF PHARMACY AND PHARMACEUTICAL SCIENCES, 2022, 25 : 137 - 148
  • [36] Update of ALDH as a Potential Biomarker and Therapeutic Target for AML
    Yang, Xiangchou
    Yao, Rongxin
    Wang, Hong
    BIOMED RESEARCH INTERNATIONAL, 2018, 2018
  • [37] NALCN is a potential biomarker and therapeutic target in human cancers
    He, Jian
    Xu, Jie
    Chang, Zhiwei
    Yan, Jiaqin
    Zhang, Limin
    Qin, Yanru
    FRONTIERS IN GENETICS, 2023, 14
  • [38] Calcium-activated proteolysis as a therapeutic target in cerebrovascular disease
    Lee, KS
    Yanamoto, H
    Fergus, A
    Hong, SC
    Kang, SD
    Cappelletto, B
    Toyoda, T
    Kassell, NF
    Bavbek, M
    Kwan, AL
    NEUROPROTECTIVE AGENTS - THIRD INTERNATIONAL CONFERENCE, 1997, 825 : 95 - 103
  • [39] Microbiota in cerebrovascular disease: A key player and future therapeutic target
    Tonomura, Shuichi
    Ihara, Masafumi
    Friedland, Robert P.
    JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 2020, 40 (07): : 1368 - 1380
  • [40] Therapeutic potential of endothelin receptor antagonists in cerebrovascular disease
    Patel, TR
    CNS DRUGS, 1996, 5 (04) : 293 - 310